Mammographic Surveillance for a 67-Year-Old Patient with History of Breast Cancer
Women with a history of breast cancer should continue annual mammography screening as long as they remain in overall good health and have a life expectancy of at least 10 years, regardless of age. 1
Recommended Surveillance Protocol
- Annual mammography is the best imaging test for surveillance in patients with a history of breast cancer, with demonstrated reduction in mortality compared to those who do not undergo annual mammography 1
- The most common presentation of recurrent or second breast cancer in patients with a personal history of breast cancer is an abnormal mammogram in an otherwise asymptomatic patient 1
- Women with a personal history of breast cancer develop a second breast cancer at a rate of 5% to 10% within 5 to 10 years after initial diagnosis 1
Duration of Surveillance
- There is no upper age limit agreed upon for screening mammography 1
- Screening recommendations should be based upon life expectancy and competing comorbidities, rather than age alone 1
- Women should continue screening mammography as long as they:
Frequency of Surveillance
- The American Society of Radiation Oncology (ASTRO) and National Comprehensive Cancer Network (NCCN) both recommend annual mammographic surveillance for women who have completed treatment for breast cancer 1
- For women treated with breast conservation therapy, the first post-treatment mammogram should be performed at 6 to 12 months after completion of radiation therapy 1
- Subsequent mammograms should be obtained annually for surveillance 1
Special Considerations for Older Patients
- More than one-third of all breast cancer deaths each year are attributable to women diagnosed after age 70 1
- Observational studies suggest that continuing annual mammography past age 75 may not result in substantial reductions in 8-year breast cancer mortality compared with stopping screening 3
- However, for women with a personal history of breast cancer (as in this case), the risk of recurrence or second primary cancer justifies continued surveillance 1
Risk Factors for Recurrence
- Factors that predict risk of locoregional recurrence include:
- Age (younger patients have higher risk)
- Tumor grade and size
- Multifocality
- Nodal involvement
- Receptor status
- Previous treatments (radiotherapy, chemotherapy, hormonal therapy) 1
- Most locoregional recurrences occur within 5 years after diagnosis, with recurrence risk greatest 2-3 years after initial therapy 1
Potential Pitfalls and Caveats
- There is suboptimal compliance with annual mammography in certain groups, particularly women over 65 years of age 1
- Some women may benefit from supplemental screening based on risk factors such as dense breast tissue or specific tumor characteristics (e.g., triple-negative or HER2-positive cancers) 1, 4
- Digital breast tomosynthesis (DBT) added to standard mammography has been shown to reduce recall rates and indeterminate findings in surveillance of patients with prior breast cancer history 1
For this 67-year-old patient with a history of breast cancer, annual mammography should be continued indefinitely as long as she remains in good health with a life expectancy of at least 10 years.